Advertisement

Prediction of Prognosis After Hemorrhagic Stroke

  • Dong-Wan Kang
  • Seung-Hoon Lee
Chapter
Part of the Stroke Revisited book series (STROREV)

Abstract

The fate of patients with intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH) is very diverse, and clinical courses during hospitalization vary as well. Therefore, it is important to predict the prognosis for patients with hemorrhagic stroke and to provide individualized care accordingly. However, there is an abundance of factors known as prognostic factors that impact the outcome of hemorrhagic stroke. Simply listing these factors would not be helpful in practice. In this chapter, we will categorize these factors in an easy-to-understand way according to pathophysiology, as follows: first, in ICH, factors will be categorized into three groups—(1) “attack factors,” which may worsen the status of the brain following a hemorrhage; (2) “protective factors,” related to the resistance of the brain against hemorrhage; and (3) “systemic and neurological states,” related to systemic and neurological conditions affecting the overall prognosis following ICH. With respect to SAH, neurological and radiological findings at the time of presentation strongly reflect the disease prognosis. Thus, we will first describe several clinical and radiological grading systems and then describe the prognostic factors associated with complications following SAH. Our hope is that this chapter will guide you to a better understanding of the prognostic factors in hemorrhagic stroke.

References

  1. 1.
    Mayer SA, Sacco RL, Shi T, et al. Neurologic deterioration in noncomatose patients with supratentorial intracerebral hemorrhage. Neurology. 1994;44:1379–84.CrossRefPubMedGoogle Scholar
  2. 2.
    Weimar C, Weber C, Wagner M, et al. Management patterns and health care use after intracerebral hemorrhage. A cost-of-illness study from a societal perspective in Germany. Cerebrovasc Dis. 2003;15:29–36.CrossRefPubMedGoogle Scholar
  3. 3.
    Rost NS, Smith EE, Chang Y, et al. Prediction of functional outcome in patients with primary intracerebral hemorrhage: the FUNC score. Stroke. 2008;39:2304–9.CrossRefPubMedGoogle Scholar
  4. 4.
    Zia E, Engstrom G, Svensson PJ, et al. Three-year survival and stroke recurrence rates in patients with primary intracerebral hemorrhage. Stroke. 2009;40:3567–73.CrossRefPubMedGoogle Scholar
  5. 5.
    Davis SM, Broderick J, Hennerici M, et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology. 2006;66:1175–81.CrossRefPubMedGoogle Scholar
  6. 6.
    Schlunk F, Greenberg SM. The pathophysiology of intracerebral hemorrhage formation and expansion. Transl Stroke Res. 2015;6:257–63.CrossRefPubMedGoogle Scholar
  7. 7.
    Demchuk AM, Dowlatshahi D, Rodriguez-Luna D, et al. Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol. 2012;11:307–14.CrossRefPubMedGoogle Scholar
  8. 8.
    Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46:2032–60.CrossRefPubMedGoogle Scholar
  9. 9.
    Boulouis G, Morotti A, Brouwers HB, et al. Association between hypodensities detected by computed tomography and hematoma expansion in patients with intracerebral hemorrhage. JAMA Neurol. 2016;73:961–8.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Li Q, Zhang G, Xiong X, et al. Black hole sign: novel imaging marker that predicts hematoma growth in patients with intracerebral hemorrhage. Stroke. 2016;47:1777–81.CrossRefPubMedGoogle Scholar
  11. 11.
    Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127–37.CrossRefPubMedGoogle Scholar
  12. 12.
    Murthy SB, Moradiya Y, Dawson J, et al. Perihematomal edema and functional outcomes in intracerebral hemorrhage: influence of hematoma volume and location. Stroke. 2015;46:3088–92.CrossRefPubMedGoogle Scholar
  13. 13.
    Balami JS, Buchan AM. Complications of intracerebral haemorrhage. Lancet Neurol. 2012;11:101–18.CrossRefPubMedGoogle Scholar
  14. 14.
    Lee SH, Kim BJ, Ryu WS, et al. White matter lesions and poor outcome after intracerebral hemorrhage: a nationwide cohort study. Neurology. 2010;74:1502–10.CrossRefPubMedGoogle Scholar
  15. 15.
    Lee SH, Bae HJ, Kwon SJ, et al. Cerebral microbleeds are regionally associated with intracerebral hemorrhage. Neurology. 2004;62:72–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Soo YO, Yang SR, Lam WW, et al. Risk vs benefit of anti-thrombotic therapy in ischaemic stroke patients with cerebral microbleeds. J Neurol. 2008;255:1679–86.CrossRefPubMedGoogle Scholar
  17. 17.
    Greenberg SM, Eng JA, Ning M, et al. Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke. 2004;35:1415–20.CrossRefPubMedGoogle Scholar
  18. 18.
    Wong KS, Chan YL, Liu JY, et al. Asymptomatic microbleeds as a risk factor for aspirin-associated intracerebral hemorrhages. Neurology. 2003;60:511–3.CrossRefPubMedGoogle Scholar
  19. 19.
    Lee SH, Ryu WS, Roh JK. Cerebral microbleeds are a risk factor for warfarin-related intracerebral hemorrhage. Neurology. 2009;72:171–6.CrossRefPubMedGoogle Scholar
  20. 20.
    Lee SH, Kim BJ, Roh JK. Silent microbleeds are associated with volume of primary intracerebral hemorrhage. Neurology. 2006;66:430–2.CrossRefPubMedGoogle Scholar
  21. 21.
    Celikbilek A, Goksel BK, Zararsiz G, et al. Spontaneous intra-cerebral hemorrhage: a retrospective study of risk factors and outcome in a Turkish population. J Neurosci Rural Pract. 2013;4:271–7.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Camacho E, Lopresti MA, Bruce S, et al. The role of age in intracerebral hemorrhages. J Clin Neurosci. 2015;22:1867–70.CrossRefPubMedGoogle Scholar
  23. 23.
    Devaraj S, Dasu MR, Jialal I. Diabetes is a proinflammatory state: a translational perspective. Expert Rev Endocrinol Metab. 2010;5:19–28.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Lee SH, Kim BJ, Bae HJ, et al. Effects of glucose level on early and long-term mortality after intracerebral haemorrhage: the acute brain bleeding analysis study. Diabetologia. 2010;53:429–34.CrossRefPubMedGoogle Scholar
  25. 25.
    Deogaonkar A, De Georgia M, Bae C, et al. Fever is associated with third ventricular shift after intracerebral hemorrhage: pathophysiologic implications. Neurol India. 2005;53:202–6.CrossRefPubMedGoogle Scholar
  26. 26.
    Schwarz S, Hafner K, Aschoff A, et al. Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology. 2000;54:354–61.CrossRefPubMedGoogle Scholar
  27. 27.
    Rossi S, Zanier ER, Mauri I, et al. Brain temperature, body core temperature, and intracranial pressure in acute cerebral damage. J Neurol Neurosurg Psychiatry. 2001;71:448–54.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Broessner G, Beer R, Lackner P, et al. Prophylactic, endovascularly based, long-term normothermia in ICU patients with severe cerebrovascular disease: bicenter prospective, randomized trial. Stroke. 2009;40:e657–65.CrossRefPubMedGoogle Scholar
  29. 29.
    Saloheimo P, Ahonen M, Juvela S, et al. Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death. Stroke. 2006;37:129–33.CrossRefPubMedGoogle Scholar
  30. 30.
    Dowlatshahi D, Butcher KS, Asdaghi N, et al. Poor prognosis in warfarin-associated intracranial hemorrhage despite anticoagulation reversal. Stroke. 2012;43:1812–7.CrossRefPubMedGoogle Scholar
  31. 31.
    Al-Khindi T, Macdonald RL, Schweizer TA. Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke. 2010;41:e519–36.CrossRefPubMedGoogle Scholar
  32. 32.
    Frontera JA, Claassen J, Schmidt JM, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery. 2006;59:21–7.CrossRefPubMedGoogle Scholar
  33. 33.
    Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 1968;28:14–20.CrossRefPubMedGoogle Scholar
  34. 34.
    Teasdale GM, Drake CG, Hunt W, et al. A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J Neurol Neurosurg Psychiatry. 1988;51:1457.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Degen LA, Dorhout Mees SM, Algra A, et al. Interobserver variability of grading scales for aneurysmal subarachnoid hemorrhage. Stroke. 2011;42:1546–9.CrossRefPubMedGoogle Scholar
  36. 36.
    Jaja BN, Cusimano MD, Etminan N, et al. Clinical prediction models for aneurysmal subarachnoid hemorrhage: a systematic review. Neurocrit Care. 2013;18:143–53.CrossRefPubMedGoogle Scholar
  37. 37.
    Jaja BNR, Saposnik G, Lingsma HF, et al. Development and validation of outcome prediction models for aneurysmal subarachnoid haemorrhage: the SAHIT multinational cohort study. BMJ. 2018;360:j5745.CrossRefPubMedGoogle Scholar
  38. 38.
    Mocco J, Ransom ER, Komotar RJ, et al. Preoperative prediction of long-term outcome in poor-grade aneurysmal subarachnoid hemorrhage. Neurosurgery. 2006;59:529–38.CrossRefPubMedGoogle Scholar
  39. 39.
    Rosen DS, Macdonald RL. Grading of subarachnoid hemorrhage: modification of the World Federation of Neurosurgical Societies scale on the basis of data for a large series of patients. Neurosurgery. 2004;54:566–75.CrossRefPubMedGoogle Scholar
  40. 40.
    Claassen J, Bernardini GL, Kreiter K, et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke. 2001;32:2012–20.CrossRefPubMedGoogle Scholar
  41. 41.
    Howington JU, Kutz SC, Wilding GE, et al. Cocaine use as a predictor of outcome in aneurysmal subarachnoid hemorrhage. J Neurosurg. 2003;99:271–5.CrossRefPubMedGoogle Scholar
  42. 42.
    Lasner TM, Weil RJ, Riina HA, et al. Cigarette smoking-induced increase in the risk of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg. 1997;87:381–4.CrossRefPubMedGoogle Scholar
  43. 43.
    Ohman J, Servo A, Heiskanen O. Risks factors for cerebral infarction in good-grade patients after aneurysmal subarachnoid hemorrhage and surgery: a prospective study. J Neurosurg. 1991;74:14–20.CrossRefPubMedGoogle Scholar
  44. 44.
    Harrod CG, Bendok BR, Batjer HH. Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage: a review. Neurosurgery. 2005;56:633–54.CrossRefPubMedGoogle Scholar
  45. 45.
    De Rooij NK, Rinkel GJ, Dankbaar JW, et al. Delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review of clinical, laboratory, and radiological predictors. Stroke. 2013;44:43–54.CrossRefPubMedGoogle Scholar
  46. 46.
    Larsen CC, Astrup J. Rebleeding after aneurysmal subarachnoid hemorrhage: a literature review. World Neurosurg. 2013;79:307–12.CrossRefPubMedGoogle Scholar
  47. 47.
    Tang C, Zhang TS, Zhou LF. Risk factors for rebleeding of aneurysmal subarachnoid hemorrhage: a meta-analysis. PLoS One. 2014;9:e99536.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Van Donkelaar CE, Bakker NA, Veeger NJ, et al. Predictive factors for rebleeding after aneurysmal subarachnoid hemorrhage: rebleeding aneurysmal subarachnoid hemorrhage study. Stroke. 2015;46:2100–6.CrossRefPubMedGoogle Scholar
  49. 49.
    Chen S, Luo J, Reis C, et al. Hydrocephalus after subarachnoid hemorrhage: pathophysiology, diagnosis, and treatment. Biomed Res Int. 2017;2017:8584753.PubMedPubMedCentralGoogle Scholar
  50. 50.
    Wilson CD, Safavi-Abbasi S, Sun H, et al. Meta-analysis and systematic review of risk factors for shunt dependency after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2017;126:586–95.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media Singapore 2018

Authors and Affiliations

  1. 1.Gangjin Public Health CenterGangjinSouth Korea
  2. 2.Department of NeurologySeoul National University HospitalSeoulSouth Korea
  3. 3.Korean Cerebrovascular Research InstituteSeoulSouth Korea

Personalised recommendations